Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance: The GAUSS-2 Randomized, Placebo-Controlled Phase 3 Clinical Trial of Evolocumab

Study Questions:

What is the efficacy and safety of subcutaneous (SC) evolocumab compared with oral ezetimibe in hypercholesterolemic subjects unable to tolerate effective statin doses?